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INTRODUCTION 
The sudden loss of kidney function is known as acute kidney 
injury (AKI), and is referred to as pediatric AKI or pAKI in 
the neonate, infant, and child. Characterized clinically by a 
decrease in kidney filtration that can usually be reversed, as 
well as the inability of the kidney to appropriately regulate 
fluid and electrolyte homeostasis [1,2], pAKI can lead to 
serious complications in kidney function later in life, known as 
chronic kidney disease (CKD). To date, underlying factors 
involved in the etiology of pAKI are not known.  
MicroRNAs (miRNAs) are a class of functional single 
stranded non-coding, small ribonucleic acid molecules [3].
 
These post-transcriptional regulators modify the expression of 
genes by acting on the mRNA that is transcribed from a gene 
(or multiple mRNAs), and thus, affect the translation of 
encoded protein [3,4]. miRNAs have been implicated in the 
etiology of AKI in adult animals, but their role in pAKI is not 
known. This preliminary research aims to determine potential 
regulatory genes targeted by miRNAs in the developing ovine 
kidney, and to explore whether any of these genes are altered 
in an experimental model of pAKI. 
METHODS 
Animals used were Ovies aries (sheep, ~15 to 20 days 
postnatal, sacrificed). Kidney tissues were harvested and snap 
frozen. Two tissues were evaluated: AKI [Treated with 
lipopolysaccharide (0.03 mg/kg) and Indomethacin (1 mg/kg)] 
and Control (Untreated). 
 
miRNA was extracted from both tissues using the mirVana 
miRNA Isolation Kit. Samples were sequenced in the ACHRI 
Genomes Facility. Using MicroCosm Targets genes/miRNAs 
were evaluated and plotted using Microsoft Excel. After 
generation of all genes, those with ≥1.5 fold change (AKI vs. 
Control) were selected for analyses.  
 
RESULTS 
A total of 103 miRNAs were present in Control and AKI 
tissue, in which the number of down-regulated genes (n=74) 
far exceeded the number up-regulated (n=27). A greater 
number of down-regulated genes exhibited ≥1.5-fold, ≥2.0-
fold and ≥3.0 fold changes as compared to up-regulated genes. 
Oar-miR-380-3p_st (GGUGGAUAUUCCUUCUAUGUUU, 
fold-change = -2.1521) was found to be down-regulating the 
expression of cyclo-oxygenase (COX1, COX7C) and nitric 
oxide  (NOX1) genes. 
 
Table 1. MicroRNAs measured in ovine renal tissue. The 
number of genes down-regulated, up-regulated, and 
unchanged are shown as fold-change in AKI as compared to 
Control tissue. 
 
SUMMARY AND CONCLUSIONS 
There were notable changes in miRNAs in AKI compared to 
Control tissue. Substantially fewer up-regulated genes than 
down-regulated genes, including COX1, COX7C, and NOX1 
genes were observed (Table 1). Target genes within the COX 
and NOX pathways which are known to modulate kidney 
haemodynamics and function may reveal their altered roles in 
AKI.  
 
Given the evolutionary conservation of miRNA regulatory 
circuits [4,5], a subset of candidate miRNAs in ovine tissue 
could be identified and validated for application to pAKI in 
future studies. Through the successful application of miRNA 
analyses to establish regulatory genes in ovine kidney tissue, 
we may further our understanding of the causes and 
consequences of pAKI, the deleterious effects of pAKI on 
kidney function, and the progression from pAKI to CKD. 
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Fold change Down-regulated Up-regulated No change 
≥ ±3.0 4 1 0 
≥ ±2.0 9 2 0 
≥ ±1.5 34 5 0 
0 0 0 2 
